Stanford University Cancer Institute

Stanford, California 94305

1 studies enrolling now · 14 studies all time

What they study most

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4)

Studies at this site

Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer — Recruiting now
Vitamin D and Breast Cancer: Does Weight Make a Difference? — Stopped early
Molecular and Cellular Analysis of Breast Cancer — Completed
Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR) — Completed
Transrectal Photoacoustic Imaging of the Prostate — Stopped early
Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma — Completed
Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study — Completed
Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia — Stopped early
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer — Stopped early
Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors — Stopped early
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis — Completed
Cancer Biology of Retinoblastoma — Stopped early
Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT — Withdrawn before enrolling
Phase I: At-Home Support for Rural Women Using Group Video Calling — Completed